Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Molycorp (NYSE: MCP) started the new year right where it left 2010 off, surging 14% after a Wall Street firm reiterated its buy rating on the rare earth producer.

So what: Dahlman Rose, which actually co-managed Molycorp's IPO, raised its price target more than 70% from $49 per share to a whopping $85 per share. Not surprisingly, Rare Element Resources (AMEX: REE) and the Market Vectors Rare Earth/Strategic Metals ETF (NYSE: REMX) are also up big on the bullish report.

Now what: Molycorp just keeps on rolling, but most investors still shouldn't buy into the rare earth bubble. Molycorp's valuation was already tough to justify at much lower prices, so betting on Dahlman Rose's $85 price target -- suggesting a market cap of about $7 billion -- just seems like a losing proposition. Of course, Molycorp's massive momentum has made this worry wart look silly recently and could certainly continue doing so!

Interested in more info on Molycorp? Add it to your watchlist.

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. Try any of our Foolish newsletter services free for 30 days.

True to its name, The Motley Fool is made up of a motley assortment of writers and analysts, each with a unique perspective; sometimes we agree, sometimes we disagree, but we all believe in the power of learning from each other through our Foolish community. The Fool's disclosure policy always gets a perfect score.